Susquehanna Fundamental Investments, LLC Vaxart, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $130,930 - $202,652	-30,520 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $231,723 - $319,673	-40,160 Reduced 56.82%	30,520 $191,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $357,640 - $761,930	70,680 New	70,680 $529,000
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $118,440 - $489,929	-21,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $43,050 - $98,154	-12,300 Reduced 36.94%	21,000 $120,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $159,174 - $565,101	33,300 New	33,300 $221,000

109

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $75.9M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.